Squarepoint’s VivoSim Labs VIVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-1,253
Closed -$119K 3327
2020
Q3
$119K Buy
1,253
+235
+23% +$30.3K ﹤0.01% 2247
2020
Q2
$134K Buy
+1,018
New +$124K ﹤0.01% 1947
2020
Q1
Sell
-47
Closed -$4K 2643
2019
Q4
$4K Buy
+47
New +$4.4K ﹤0.01% 2439
2019
Q1
Sell
-56
Closed -$13K 2494
2018
Q4
$13K Sell
56
-48
-46% -$12.1K ﹤0.01% 1880
2018
Q3
$29K Sell
104
-35
-25% -$10.5K ﹤0.01% 1935
2018
Q2
$47K Buy
139
+52
+60% +$17.1K ﹤0.01% 1692
2018
Q1
$22K Sell
87
-62
-42% -$18.1K ﹤0.01% 1628
2017
Q4
$48K Buy
+149
New +$55.4K ﹤0.01% 2019
2017
Q1
Sell
-206
Closed -$167K 1959
2016
Q4
$167K Buy
+206
New +$164K 0.01% 1502
2015
Q3
Sell
-122
Closed -$110K 609
2015
Q2
$110K Buy
+122
New +$136K 0.04% 401

Other funds holding VIVS

Squarepoint's VIVS Position: Q4 2020 in Review

Squarepoint sold out of VivoSim Labs (VIVS) in Q4 2020, closing a stake of 1,253 shares — an estimated $119K sold.

Squarepoint first reported a position in VIVS in Q2 2015 and held it in 10 quarters. The position peaked at $167K in Q4 2016. 46 funds tracked by Wall St. Rank hold VIVS as of Q4 2020.

  • Squarepoint reported no remaining VivoSim Labs position as of Q4 2020 after selling out during the quarter.
  • Squarepoint sold 1,253 VivoSim Labs shares in Q4 2020, an estimated $119K.
  • Squarepoint first reported a position in VivoSim Labs in Q2 2015 and held it in 10 quarters.
  • Squarepoint's VivoSim Labs position peaked at $167K in Q4 2016.
  • 46 funds tracked by Wall St. Rank held VivoSim Labs as of Q4 2020.

Based on Squarepoint's 13F filing for Q4 2020, filed 16 Feb 2021.